Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

News > Suppliers

Read more breaking news



Nestlé quiet on Pfizer Nutrition-driven Latin American assets sale rumour

By Mark Astley , 10-Jan-2013
Last updated on 10-Jan-2013 at 17:22 GMT2013-01-10T17:22:31Z

Nestlé quiet on Pfizer Nutrition-driven Latin American assets sale

Nestlé has refused to comment on reports that it is working with financial advisory group Rothschild to sell more than $1bn of Latin American assets in an effort to win regulatory approval for its acquisition of Pfizer Nutrition.

Bloomberg reported yesterday that the food and beverage giant is in the early stages of a process to sell assets in a number of Latin American countries to meet the demands of competition authorities in the region. approached Switzerland-based Nestlé, but the company declined to confirm or deny the reports.

“We never comment about reports of possible acquisitions or divestitures, or about on-going regulatory processes,” said Nestlé spokesperson, Philippe Aeschlimann.

Financial advisory group Rothschild was also contacted, but declined to comment on the reports.

Regulatory processes “on-going”

Nestlé spokesperson Aeschlimann confirmed, however, that regulatory processes are still on-going in five Latin American countries including Chile, Colombia, Ecuador, Mexico and Nicaragua.

Anti-trust authorities in South Africa and Kenya are also yet to approve the deal.

According to the Bloomberg report, Mexico is likely to be among the countries targeted for divestment.

The Mexican Federal Competition (CFC) declined to authorize the acquisition in November 2012, citing concerns that the deal could lead to price increases of up to 11.5%.

It is assumed that the rumoured Latin American carve-up will draw interest from global infant formula manufacturers such as Danone, Mead Johnson Nutrition, and Abbott Laboratories.

"Not material to the deal"

Nestlé completed the $11.85bn (€9bn) acquisition of Pfizer Nutrition in December 2012, despite still seeking approval from competition authorities in the five Latin American nations, South Africa and Kenya.

A spokesperson for Nestlé previously told that these markets, which represent less than 15% of Pfizer Nutrition’s sales, are “not material to the deal.”

By December 2012, more than 85% of the markets that Pfizer Nutrition operates in had given the deal the go-ahead – allowing its closure under the terms of the April 2012 agreement between Nestlé and Pfizer.

The Chinese Ministry of Commerce (MOFCOM) and the Australian Competition and Consumer Commission (ACCC) approved the deal in November 2012 – following in the footsteps of the Brazilian Council for Economic Defence (CADE) and the Competition Commission of India (CCI).

Related products

Live Supplier Webinars

Polyphenols tipped to become the way to innovate in Sports Nutrition
Alpha & Omega in Sports Nutrition – Using Omega 3’s and A-GPC to improve performance and recovery.
KD Pharma
Orally bioavailable standardized botanical derivatives in sport nutrition: special focus on recovery in post-intense physical activities
Collagen in motion: move freely and keep your injuries in check
Leading manufacturer of gelatine and collagen peptides
Life’s too short for slow proteins. Whey proteins hydrolysates: Fast delivery for enhanced performance
Arla Foods Ingredients
What it Takes to Compete and Win in Today’s Sports Nutrition Market
Sports Nutrition Snapshot: Key regional drivers and delivery format innovations
William Reed Business Media
Gutsy performance: How can microbiome modulation help athletes and weekend warriors
William Reed Business Media
Pushing the boundaries: Where’s the line between ‘cutting edge nutrition’ and doping
William Reed Business Media

On demand Supplier Webinars

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?
Balancing Innovation and Risk in Sports Nutrition Ingredients
Explaining bio-hacking: is there a marketing opportunity for food companies?
William Reed Business Media
Personalized Nutrition – how an industry can take part in shaping the future of Nutrition
BASF Nutrition & Health
Find out Nutritional and ingredient lifecycle solutions and strategies!
Is the time rIpe for I-nutrition?
William Reed Business Media
The Advantage of Outsourcing Fermentation-based Manufacturing Processes
Evonik Health Care
All supplier webinars

Promotional Features

Content Provided by Fonterra

Way forward with whey protein